Capstone Investment Advisors, LLC Ptc Therapeutics, Inc. Transaction History
Capstone Investment Advisors, LLC
- $30.4 Billion
- Q3 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 68,200 shares of PTCT stock, worth $3.04 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
68,200Holding current value
$3.04 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$407 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$352 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$347 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$330 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$323 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.19B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...